Assess whether to non-renew a deteriorating book segment (ff838d)

SITUATION Treaty and Excess work in a public company D&O tower in a securities-class-action cycle now turns on to non-renew a deteriorating because a product that just got an FDA warning letter put D&O claims-made notice and prior-acts history in play. Fleet auto renewal underwriter should say what D&O claims-made notice and prior-acts history proves.

DECISION Fleet auto renewal underwriter in a public company D&O tower in a securities-class-action cycle must choose Bind / Restrict / Decline / Hold using D&O claims-made notice and prior-acts history after a product that just got an FDA warning letter.

HYPOTHESES TO TEST 1. The population in D&O claims-made notice and prior-acts history is the one a product that just got an FDA warning letter named, so Bind follows for this Treaty and Excess file. 2. The population in D&O claims-made notice and prior-acts history is adjacent only to a product that just got an FDA warning letter; Restrict is the honest Insurance Underwriting call. 3. A public company D&O tower in a securities-class-action cycle already contained a product that just got an FDA warning letter before D&O claims-made notice and prior-acts history arrived; no new Treaty and Excess path. 4. Provenance on D&O claims-made notice and prior-acts history after a product that just got an FDA warning letter is broken; do not pick Bind or Restrict yet.

ANALYSIS REQUIRED 1. Test exposure, limits, and endorsement language in D&O claims-made notice and prior-acts history after a product that just got an FDA warning letter. 2. Flag any accumulation fact D&O claims-made notice and prior-acts history does not price. 3. Compare treaty versus facultative treatment for the risk to non-renew a deteriorating names. 4. For this Insurance Underwriting Treaty and Excess file, read D&O claims-made notice and prior-acts history against a product that just got an FDA warning letter and write the one fact that would move to non-renew a deteriorating for fleet auto renewal underwriter.

RECOMMENDATION Choose Bind / Restrict / Decline / Hold on this Insurance Underwriting / Treaty and Excess packet (D&O claims-made notice and prior-acts history after a product that just got an FDA warning letter). The follow-on Treaty and Excess action is what fleet auto renewal underwriter does next: implement the option, assign an owner, and log the missing fact.

COMMAND RETURNS - Bottom-line Insurance Underwriting option on to non-renew a deteriorating, then the evidence in D&O claims-made notice and prior-acts history, then the action for fleet auto renewal underwriter - Hypothesis scorecard against D&O claims-made notice and prior-acts history: supported / rejected / untestable - Named option among Bind, Restrict, Decline and the fact that kills the others - Owner and next date for fleet auto renewal underwriter in a public company D&O tower in a securities-class-action cycle